One wonders why neurosurgeons were not interested in doing the trial. Would you recruit an orthopaedist to perform research into brain surgery?
The announcement reads like a cheap advertisement. The more I read through it, the more trashy it looks. It's very low on detail, and the detail they do have is highly questionabble.
eg. what the hell does this mean?? "Almost half the nerve repairs (11 of 25) were performed in three quadriplegic patients".
then they say "CelGro® facilitates tensionless repair of peripheral nerve". huh ???
One has to put these two sentences together to work out they're talking about functional quadriplegia. Not mentioned in the announcement. I wonder why.
Lost all trust in this company.
Ann: CelGro Nerve Regeneration Results in Quadriplegic Patients, page-133
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
65.5¢ |
Change
0.015(2.34%) |
Mkt cap ! $156.6M | |||
| Open | High | Low | Value | Volume |
| 64.5¢ | 69.0¢ | 64.0¢ | $707.4K | 1.056M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 169 | 65.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 68.0¢ | 15538 | 2 |
View Market Depth
| Last trade - 16.10pm 11/11/2024 (20 minute delay) ? |
| OCC (ASX) Chart |